This systematic review demonstrates that distress levels in partners of ICD patients are as high as in patients themselves, although there was a tendency for increased anxiety levels in partners ...
Please provide your email address to receive an email when new articles are posted on . Remote ICD deactivation for patients receiving hospice care was successful in a small feasibility study.
"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...
For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...
AURORA, CO — Almost 80% of older patients who received an implantable cardioverter defibrillator (ICD) for secondary prevention after being resuscitated for cardiac arrest lived at least 2 years ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In certain patients with an ICD for primary prevention, ...
Implantable cardioverter defibrillators (ICDs) were found to have a beneficial effect on mortality in patients with chronic kidney disease (CKD). Mortality in patients with chronic kidney disease (CKD ...
Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 6-month follow-up results of TRINITY Trial of LuX-Valve Plus, a ...
Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ventricular systolic dysfunction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results